ACT Genomics Co. Limited, Asia's foremost provider of next-generation sequencing (NGS) precision oncology, is proud to ...
NeoGenomics, Inc.’s NEO share price has dipped by 10.05%, which has investors questioning if this is right time to buy.
Genomics (NASDAQ:TXG – Get Free Report)‘s stock had its “sell (e+)” rating restated by equities researchers at Weiss Ratings in a note issued to investors on Friday,Weiss Ratings reports. A number of ...
Genomics (NASDAQ:TXG – Get Free Report) had its price target reduced by investment analysts at Citigroup from $20.00 to $15.00 in a note issued to investors on Tuesday,Benzinga reports. The brokerage ...
SAN DIEGO, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO)(the “Company”) today announced that it will effect a reverse stock split of its issued and outstanding common ...
10X Genomics, Inc. is a life science technology company, which engages in building products to interrogate, understand and master biology. Its integrated solutions include single cell ...
The DNA polymerase market in the United States is poised for significant expansion, with projections indicating a market size of USD 148.7 million by 2025 and a compound annual growth rate (CAGR) of 5 ...
The dna polymerase market in australia and new zealand is witnessing substantial growth, fueled by rapid advancements in genomics, increased applications in diagnostics, and expanding research in ...
Learn more about whether Alignment Healthcare, Inc. or GeneDx Holdings Corp. is a better investment based on AAII's A+ ...
"Our new fiscal 2025 guidance provides for limited further earnings contribution from China, and assumes a continuation of the macro trends we see today," said Ankur Dhingra, CFO of Illumina. "We will ...
GARDEN CITY, NY, March 07, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) (“ProPhase” or the “Company”), a next-generation biotech, genomics, and consumer products company, today ...
We recently compiled a list of the 10 Best Emerging Technology Stocks to Buy Now. In this article, we are going to take a ...